SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001634432-20-000030
Filing Date
2020-07-07
Accepted
2020-07-07 07:59:03
Documents
3
Period of Report
2020-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbbp-20200702x8k.htm 8-K 37144
2 EX-99.1 sbbp-20200702ex99133f3db.htm EX-99.1 11815
3 GRAPHIC sbbp-20200702ex99133f3db001.jpg GRAPHIC 4922
  Complete submission text file 0001634432-20-000030.txt   57222
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 201015252
SIC: 2834 Pharmaceutical Preparations